Nicole H Tobin, Aisling Murphy, Fan Li, Sean S Brummel, Taha E Taha, Friday Saidi, Maxie Owor, Avy Violari, Dhayendre Moodley, Benjamin Chi, Kelli D Goodman, Brian Koos, Grace M Aldrovandi
{"title":"干血斑与血浆非靶向代谢组学的比较。","authors":"Nicole H Tobin, Aisling Murphy, Fan Li, Sean S Brummel, Taha E Taha, Friday Saidi, Maxie Owor, Avy Violari, Dhayendre Moodley, Benjamin Chi, Kelli D Goodman, Brian Koos, Grace M Aldrovandi","doi":"10.1007/s11306-021-01813-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain.</p><p><strong>Objectives: </strong>The primary goal of this study was to compare the ability of DBS- and plasma-based assays to characterize maternal metabolites. Utility of the two assays was also assessed in the context of a case-control predictive model in pregnant women living with HIV.</p><p><strong>Methods: </strong>Untargeted metabolomics was performed on archived paired maternal plasma and DBS from n = 79 women enrolled in a large clinical trial.</p><p><strong>Results: </strong>A total of 984 named biochemicals were detected across both plasma and DBS samples, of which 627 (63.7%), 260 (26.4%), and 97 (9.9%) were detected in both plasma and DBS, plasma alone, and DBS alone, respectively. Variation attributable to study individual (R<sup>2</sup> = 0.54, p < 0.001) exceeded that of the sample type (R<sup>2</sup> = 0.21, p < 0.001), suggesting that both plasma and DBS were capable of differentiating individual metabolomic profiles. Log-transformed metabolite abundances were strongly correlated (mean Spearman rho = 0.51) but showed low agreement (mean intraclass correlation of 0.15). However, following standardization, DBS and plasma metabolite profiles were strongly concordant (mean intraclass correlation of 0.52). Random forests classification models for cases versus controls identified distinct feature sets with comparable performance in plasma and DBS (86.5% versus 91.2% mean accuracy, respectively).</p><p><strong>Conclusion: </strong>Maternal plasma and DBS samples yield distinct metabolite profiles highly predictive of the individual subject. In our case study, classification models showed similar performance albeit with distinct feature sets. Appropriate normalization and standardization methods are critical to leverage data from both sample types. Ultimately, the choice of sample type will likely depend on the compounds of interest as well as logistical demands.</p>","PeriodicalId":144887,"journal":{"name":"Metabolomics : Official journal of the Metabolomic Society","volume":" ","pages":"62"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11306-021-01813-3","citationCount":"10","resultStr":"{\"title\":\"Comparison of dried blood spot and plasma sampling for untargeted metabolomics.\",\"authors\":\"Nicole H Tobin, Aisling Murphy, Fan Li, Sean S Brummel, Taha E Taha, Friday Saidi, Maxie Owor, Avy Violari, Dhayendre Moodley, Benjamin Chi, Kelli D Goodman, Brian Koos, Grace M Aldrovandi\",\"doi\":\"10.1007/s11306-021-01813-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain.</p><p><strong>Objectives: </strong>The primary goal of this study was to compare the ability of DBS- and plasma-based assays to characterize maternal metabolites. Utility of the two assays was also assessed in the context of a case-control predictive model in pregnant women living with HIV.</p><p><strong>Methods: </strong>Untargeted metabolomics was performed on archived paired maternal plasma and DBS from n = 79 women enrolled in a large clinical trial.</p><p><strong>Results: </strong>A total of 984 named biochemicals were detected across both plasma and DBS samples, of which 627 (63.7%), 260 (26.4%), and 97 (9.9%) were detected in both plasma and DBS, plasma alone, and DBS alone, respectively. Variation attributable to study individual (R<sup>2</sup> = 0.54, p < 0.001) exceeded that of the sample type (R<sup>2</sup> = 0.21, p < 0.001), suggesting that both plasma and DBS were capable of differentiating individual metabolomic profiles. Log-transformed metabolite abundances were strongly correlated (mean Spearman rho = 0.51) but showed low agreement (mean intraclass correlation of 0.15). However, following standardization, DBS and plasma metabolite profiles were strongly concordant (mean intraclass correlation of 0.52). Random forests classification models for cases versus controls identified distinct feature sets with comparable performance in plasma and DBS (86.5% versus 91.2% mean accuracy, respectively).</p><p><strong>Conclusion: </strong>Maternal plasma and DBS samples yield distinct metabolite profiles highly predictive of the individual subject. In our case study, classification models showed similar performance albeit with distinct feature sets. Appropriate normalization and standardization methods are critical to leverage data from both sample types. Ultimately, the choice of sample type will likely depend on the compounds of interest as well as logistical demands.</p>\",\"PeriodicalId\":144887,\"journal\":{\"name\":\"Metabolomics : Official journal of the Metabolomic Society\",\"volume\":\" \",\"pages\":\"62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s11306-021-01813-3\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Metabolomics : Official journal of the Metabolomic Society\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11306-021-01813-3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolomics : Official journal of the Metabolomic Society","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11306-021-01813-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10
摘要
非靶向代谢组学在生物标志物检测和开发方面具有重要的前景。在资源有限的情况下,基于干血点(DBS)的平台将比需要冷供应链的基于血浆的方法具有显著优势。目的:本研究的主要目的是比较DBS和基于血浆的检测方法表征母体代谢物的能力。在HIV感染孕妇的病例对照预测模型中,对这两种检测方法的效用也进行了评估。方法:对一项大型临床试验中n = 79名女性的配对母体血浆和DBS进行非靶向代谢组学研究。结果:在血浆和DBS样品中共检测到984种命名生化物质,其中血浆和DBS中分别检测到627种(63.7%)、260种(26.4%)和97种(9.9%)。研究个体差异(R2 = 0.54, p 2 = 0.21, p)结论:母体血浆和DBS样品产生不同的代谢物谱,可高度预测个体受试者。在我们的案例研究中,分类模型显示了相似的性能,尽管具有不同的特征集。适当的规范化和标准化方法对于利用来自这两种样本类型的数据至关重要。最终,样品类型的选择可能取决于感兴趣的化合物以及后勤需求。
Comparison of dried blood spot and plasma sampling for untargeted metabolomics.
Introduction: Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain.
Objectives: The primary goal of this study was to compare the ability of DBS- and plasma-based assays to characterize maternal metabolites. Utility of the two assays was also assessed in the context of a case-control predictive model in pregnant women living with HIV.
Methods: Untargeted metabolomics was performed on archived paired maternal plasma and DBS from n = 79 women enrolled in a large clinical trial.
Results: A total of 984 named biochemicals were detected across both plasma and DBS samples, of which 627 (63.7%), 260 (26.4%), and 97 (9.9%) were detected in both plasma and DBS, plasma alone, and DBS alone, respectively. Variation attributable to study individual (R2 = 0.54, p < 0.001) exceeded that of the sample type (R2 = 0.21, p < 0.001), suggesting that both plasma and DBS were capable of differentiating individual metabolomic profiles. Log-transformed metabolite abundances were strongly correlated (mean Spearman rho = 0.51) but showed low agreement (mean intraclass correlation of 0.15). However, following standardization, DBS and plasma metabolite profiles were strongly concordant (mean intraclass correlation of 0.52). Random forests classification models for cases versus controls identified distinct feature sets with comparable performance in plasma and DBS (86.5% versus 91.2% mean accuracy, respectively).
Conclusion: Maternal plasma and DBS samples yield distinct metabolite profiles highly predictive of the individual subject. In our case study, classification models showed similar performance albeit with distinct feature sets. Appropriate normalization and standardization methods are critical to leverage data from both sample types. Ultimately, the choice of sample type will likely depend on the compounds of interest as well as logistical demands.